NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) filed its 510(k) submission to the FDA for trigeminal nerve ablation on Wednesday, earlier than previously guided. NeuroOne Medical is ...
(RTTNews) - NeuroOne Medical Technologies Corp. (NMTC) on Wednesday announced that it has completed its 510(k) submission to the U.S. Food and Drug Administration for its OneRF Trigeminal Nerve ...
Nerve ablation uses heat to destroy nerves and decrease chronic pain signals. This procedure often takes 15 minutes to an ...
LAS VEGAS -- Overactive bladder (OAB) symptoms in women improved rapidly and significantly following a single treatment with transvaginal radiofrequency (RF) nerve ablation, a small prospective study ...
EDEN PRAIRIE, Minn., April 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...
VNS is the process of electrically stimulating the vagus nerve via a surgically implanted device. It is generally safe, but may cause temporary side effects, such as hoarseness, coughing, and ...
EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care ...
This clearance leverages the Company’s proprietary OneRF ® Ablation System RF generator platform for the treatment of trigeminal neuralgia, a chronic pain condition affecting approximately 150,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback